Cargando…

Safety and Immunogenicity of a Stable, Cold-Adapted, Temperature-Sensitive/Conditional Lethal Enterovirus A71 in Monkey Study

Enterovirus A71 (EV-A71) and coxsackievirus A16 (CA16) are major etiological agents of hand foot and mouth disease (HFMD) in children, which may result in fatal neurological complications. The development of safe, cost effective vaccines against HFMD, especially for use in developing countries, is s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chua, Kaw Bing, Ng, Qimei, Meng, Tao, Jia, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001754/ https://www.ncbi.nlm.nih.gov/pubmed/33803356 http://dx.doi.org/10.3390/v13030438

Ejemplares similares

Development of stable, cold-adapted, temperature-sensitive/conditional lethal chimeric enterovirus A71 and coxsackievirus A16
por: Chua, Kaw Bing, et al.
Publicado: (2022)

Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)
por: Victorio, Carla Bianca Luena, et al.
Publicado: (2014)

A clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema
por: Victorio, Carla Bianca Luena, et al.
Publicado: (2016)

Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain)
por: Victorio, Carla Bianca Luena, et al.
Publicado: (2016)

VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment
por: Chen, Fang-Hong, et al.
Publicado: (2019)

Adaptation and Virulence of Enterovirus-A71
por: Kobayashi, Kyousuke, et al.
Publicado: (2021)

Suppression of interleukin-6 increases enterovirus A71 lethality in mice
por: Wang, Li-Chiu, et al.
Publicado: (2017)

A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans
por: Meng, Tao, et al.
Publicado: (2021)

Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys
por: In, Hyun Ju, et al.
Publicado: (2018)

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine
por: Hwa, Shi-Hsia, et al.
Publicado: (2013)

Mechanism for the lethal effect of enterovirus A71 intracerebral injection in neonatal mice
por: Feng, Min, et al.
Publicado: (2019)

Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections
por: Liu, Jiangning, et al.
Publicado: (2020)

Adaptation of Enterovirus 71 to Adult Interferon Deficient Mice
por: Caine, Elizabeth A., et al.
Publicado: (2013)

Receptors for enterovirus 71
por: Yamayoshi, Seiya, et al.
Publicado: (2014)

Protective effect of enterovirus-71 (EV71) virus-like particle vaccine against lethal EV71 infection in a neonatal mouse model
por: CAO, LEI, et al.
Publicado: (2015)

Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates
por: Chou, Ai-Hsiang, et al.
Publicado: (2012)

Enterovirus 71 Outbreak, Brunei
por: AbuBakar, Sazaly, et al.
Publicado: (2009)

Recombinant Human Enterovirus 71
Publicado: (2004)

The cellular receptor for enterovirus 71
por: Liu, Yue, et al.
Publicado: (2014)

Enterovirus 71 infection and vaccines
por: Yi, Eun-Je, et al.
Publicado: (2017)

Enterovirus A71 Vaccines
por: Li, Mei-Ling, et al.
Publicado: (2021)

Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques
por: Liu, Chia-Chyi, et al.
Publicado: (2014)

Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway
por: Too, Issac Horng Khit, et al.
Publicado: (2016)

Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice
por: Chang, Junliang, et al.
Publicado: (2015)

Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
por: Yee, Pinn Tsin Isabel, et al.
Publicado: (2019)

Developments towards antiviral therapies against enterovirus 71
por: Wu, Kan X., et al.
Publicado: (2010)

Cell and tissue tropism of enterovirus 71 and other enteroviruses infections
por: Lin, Jing-Yi, et al.
Publicado: (2014)

COPI Is Required for Enterovirus 71 Replication
por: Wang, Jianmin, et al.
Publicado: (2012)

Seroepidemiology of Human Enterovirus 71, Singapore
por: Ooi, Eng-Eong, et al.
Publicado: (2002)

Challenges to Licensure of Enterovirus 71 Vaccines
por: Lee, Min-Shi, et al.
Publicado: (2012)

112 The Development of Enterovirus 71 Vaccine
por: Xiuling, Li, et al.
Publicado: (2014)

Enterovirus 71 infection and neurological complications
por: Lee, Kyung Yeon
Publicado: (2016)

Antivirals and vaccines for Enterovirus A71
por: Lin, Jing-Yi, et al.
Publicado: (2019)

Cellular receptors for enterovirus A71
por: Kobayashi, Kyousuke, et al.
Publicado: (2020)

Human IgG Fc promotes expression, secretion and immunogenicity of enterovirus 71 VP1 protein
por: Xu, Juan, et al.
Publicado: (2016)

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge
por: Zhang, Fushun, et al.
Publicado: (2014)

Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses
por: Lin, Yu-Wen, et al.
Publicado: (2018)

Mapping genetic determinants of the cell-culture growth phenotype of enterovirus 71
por: Phuektes, Patchara, et al.
Publicado: (2011)

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)

Complete Genome Sequence of an Enterovirus A71 Strain Isolated in 2006 from a Patient in Shenzhen, Southern China, with a Lethal Case of Enterovirus Infection
por: Yao, Xiang-Jie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p7u3ks78beik2bdivllc0demho